Human Hepatitis B Immunoglobulin (HBIG)

Form: Injection

Strength: 100 IU or 500 IU per vial/ampoule

Reference Brands: HepaGam B®, Nabi-HB®, HyperHEP B®(US); Hepatect CP, Zutectra®, HBIG Bayer®, Beriglobin® P(EU)

Category: Hepatitis

Human Hepatitis B Immunoglobulin (HBIG) is a purified antibody preparation used for post-exposure prophylaxis against the Hepatitis B virus (HBV). Available in intramuscular (IM), intravenous (IV), and subcutaneous (SC) forms, HBIG provides immediate passive immunity in high-risk scenarios, including perinatal exposure, needle-stick injuries, and liver transplants. Leading brands like HepaGam B®, Nabi-HB®, Hepatect CP, and Zutectra® meet USFDA and EU-GMP standards. Offered in strengths such as 100 IU and 500 IU per vial, HBIG is essential in hospital, clinic, and immunization programs. Trusted for safety and efficacy, it is widely used in EU and US pharmaceutical B2B supply chains.